“Hemangiomas can be divided into two categories: hemangiomas and vascular malformations; hemangiomas refer to hemangiomas in infants and young children, which are divided into superficial, deep and mixed types, and can be divided into three periods: proliferation, quiescence and regression. Vascular malformations can be divided into capillary malformations, lymphatic malformations, venous malformations and arteriovenous malformations. For the treatment of “hemangioma”, it is necessary to make diagnosis and classification first, and different diagnosis and different periods will adopt different treatment methods. Infantile hemangioma: most of the hemangiomas can subside on their own, among the subsiding patients, 30%-38% of them will be left with local deformities, which need later cosmetic repair, most of them will start to subside from the age of 6 months, and will subside completely at the age of 5-6 years, and some of them can be up to the age of 12 years. Hyperplasia: rapid growth, large area, in special parts of the oral treatment can be used for cardiac glycosides, more than 90% can be effectively controlled; small area, limited can be used for hormone injections or anti-tumor drug treatment, superficial, small area can be used for topical thimerosal eye drops or immunomodulator imiquimod topical application. Overall, for infantile hemangiomas in the proliferative stage, early intervention is advocated to inhibit tumor enlargement even if it cannot regress, in order to reduce the residual deformity and the rate of late surgical repair. For infantile hemangiomas in the quiescent and regressive stages, they can be observed or treated with topical medications, and the color left on the surface after regression can be treated with laser therapy.